Related references
Note: Only part of the references are listed.Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease
Debashish Danda et al.
RHEUMATOLOGY (2021)
Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis
K. Bates Gribbons et al.
ARTHRITIS CARE & RESEARCH (2020)
Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America
Ruchika Goel et al.
RHEUMATOLOGY (2020)
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Large-vessel giant cell arteritis: diagnosis, monitoring and management
Matthew J. Koster et al.
RHEUMATOLOGY (2018)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Epidemiology of Takayasu arteritis
Fatos Onen et al.
PRESSE MEDICALE (2017)
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis
Carol A. Langford et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Distinctions Between Diagnostic and Classification Criteria?
Rohit Aggarwal et al.
ARTHRITIS CARE & RESEARCH (2015)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)
Anthea Craven et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
William P. Arend et al.
ARTHRITIS AND RHEUMATISM (2010)
Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients
Kathleen Maksimowicz-McKinnon et al.
ARTHRITIS AND RHEUMATISM (2007)
Share Paper
